Revista Colombiana de Cancerologia
Scope & Guideline
Empowering Cancer Research Through Collaboration
Introduction
Aims and Scopes
- Clinical Oncology:
The journal publishes research on the diagnosis, treatment, and management of various cancers, highlighting innovative clinical practices and outcomes. - Epidemiology and Public Health:
Research focusing on cancer incidence, risk factors, and population health strategies in Colombia and Latin America is a significant component of the journal's content. - Multidisciplinary Collaboration:
The journal emphasizes the importance of teamwork among various healthcare professionals in cancer care, including oncologists, surgeons, radiologists, and nurses. - Innovative Treatment Modalities:
Studies on new therapies, including targeted therapies, immunotherapy, and advances in radiotherapy, are regularly featured, reflecting the journal's commitment to cutting-edge cancer treatment. - Palliative Care and Quality of Life:
Research addressing the psychosocial aspects of cancer care, including palliative care strategies and quality of life for patients, is an essential focus area. - Case Reports and Reviews:
The journal includes case reports and literature reviews that provide insights into rare and complex cancer cases, contributing to the understanding of diverse clinical scenarios.
Trending and Emerging
- Multidisciplinary Cancer Care Models:
Recent publications emphasize the need for integrated approaches in cancer treatment, showcasing models that incorporate various specialties to improve patient outcomes. - Telemedicine and Remote Patient Management:
The rise of telemedicine, especially post-COVID-19, has led to increased research on remote care strategies, demonstrating a shift towards more accessible cancer care. - Patient-Centered Care and Quality of Life:
There is a growing focus on studies that assess patient-reported outcomes and quality of life, reflecting a broader understanding of the importance of holistic cancer care. - Innovations in Radiotherapy Techniques:
Research on novel radiotherapy methods, including intraoperative radiotherapy and advanced fractionation schemes, indicates a trend towards improving treatment precision and minimizing side effects. - Oncology Nursing and Advanced Practice:
The role of nursing in oncology, particularly advanced practice nursing, is gaining recognition, leading to an increase in related studies highlighting their impact on patient care. - Public Health Initiatives and Cancer Prevention:
There is a notable trend towards exploring public health strategies aimed at cancer prevention and early detection, addressing the need for comprehensive cancer control programs.
Declining or Waning
- Traditional Chemotherapy:
As new treatment modalities such as immunotherapy and targeted therapies gain traction, traditional chemotherapy regimens are being studied less frequently, suggesting a shift towards more innovative approaches. - Basic Science Research:
The focus on basic science and molecular biology related to cancer has diminished, possibly due to the journal's prioritization of clinical and applied research that directly impacts patient care. - Regional Cancer Disparities:
While previously a point of interest, the specific examination of regional disparities in cancer care and outcomes has become less frequent, potentially overshadowed by broader public health discussions. - Longitudinal Studies:
There has been a noticeable decrease in the publication of long-term follow-up studies, which are critical for understanding the long-term effects and outcomes of cancer treatments. - Epidemiological Studies with Limited Scope:
Epidemiological research that lacks comprehensive data or focuses narrowly on specific populations has seen a decline, possibly due to the increasing demand for data-rich studies.
Similar Journals
Nature Reviews Clinical Oncology
Pioneering Insights for Tomorrow's TreatmentsNature Reviews Clinical Oncology is a premier journal dedicated to the comprehensive exploration and critical evaluation of current advancements in the field of clinical oncology. Published by the esteemed NATURE PORTFOLIO in the United Kingdom, this influential journal boasts an impressive impact factor that reflects its significant role in shaping oncology research. As a Q1 ranked journal in Scopus, it occupies a notable position within the top tier of oncology publications, placing it in the 99th percentile among its peers. With a history of convergence from 2009 to 2024, it presents high-quality content through an open-access model, ensuring accessibility to vital research findings. Researchers, professionals, and students alike will find Nature Reviews Clinical Oncology an invaluable resource for staying abreast of the latest trends, biologic insights, and therapeutic innovations that drive the future of cancer treatment.
Cancer Reports
Bridging gaps in cancer care with cutting-edge research.Cancer Reports, published by WILEY, is an esteemed open-access journal dedicated to the field of oncology and cancer research. With a focus on disseminating impactful research findings since its transition to fully open access in 2021, Cancer Reports aims to facilitate knowledge sharing among researchers, clinicians, and healthcare professionals globally. The journal is positioned within the Q3 quartile for both Cancer Research and Oncology categories as of 2023, reflecting its commitment to quality and relevance in a competitive publishing landscape. With an ISSN of N/A and an E-ISSN of 2573-8348, the journal showcases studies across diverse aspects of cancer biology, treatment modalities, and patient care strategies. Located in the United Kingdom at 111 River St, Hoboken 07030-5774, NJ, Cancer Reports strives to contribute to the advancement of cancer research and improve health outcomes for patients worldwide, making it a pivotal platform for scholars and practitioners in the oncology community.
Cancers
Empowering discovery in oncology and cancer treatment.Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.
South Asian Journal of Cancer
Uniting expertise to combat cancer in South Asia.South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.
Tumori Journal
Bridging Research and Practice in Oncology.Tumori Journal is a distinguished publication in the field of oncology, dedicated to advancing the understanding and treatment of cancer since its inception in 1946. Published by SAGE Publications Ltd, this Italian journal serves as a pivotal platform for researchers, clinicians, and academicians to disseminate cutting-edge findings in cancer research and related areas of medicine. With an impressive record of contributions spanning multiple decades, Tumori Journal aims to foster collaboration and dialogue among professionals in the oncology community. Although classified in the Q4 category for Cancer Research and the Q3 category for both Medicine (miscellaneous) and Oncology as of 2023, the journal continues to draw interest with its rigorous peer-review process and commitment to quality. Researchers are encouraged to explore innovative methodologies and share impactful clinical insights through the journal, which also ranks within the top tiers of Scopus metrics for oncology and cancer research domains. With a growing emphasis on accessible research, Tumori Journal remains an essential resource in the continuous fight against cancer.
JNCI-Journal of the National Cancer Institute
Empowering oncologists with groundbreaking insights.JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.
Oncology in Clinical Practice
Elevating Patient Outcomes Through Innovative ResearchOncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.
LANCET ONCOLOGY
Transforming the landscape of cancer treatment and prevention.The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.
International Journal of Clinical Oncology
Leading the Charge in Oncology Research ExcellenceInternational Journal of Clinical Oncology, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing research and clinical practices in the fields of oncology, hematology, and surgery. With its impact factor reflecting its significance and reach in the academic community, this journal serves as a solid platform for researchers, professionals, and students to share and disseminate groundbreaking discoveries and methodologies. Notably, it has secured prestigious rankings in the Q1 category in Medicine (miscellaneous) and Surgery, and Q2 in Hematology and Oncology, illustrating its prominent position in the medical literature. The journal's comprehensive scope addresses pivotal clinical issues from 1996 through 2024, further solidifying its relevance in the ever-evolving landscape of cancer research. Despite not offering open access, the depth and quality of research articles ensure that vital information remains accessible to those committed to improving clinical outcomes in oncology. With a focus on innovative treatments and patient care, the International Journal of Clinical Oncology embodies a commitment to fostering excellence in medical research.
Onkologija
Bridging clinical practice and groundbreaking oncology insights.Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.